Summary
Melt phase condensation of L‐lactic acid with heterogeneous catalysts was performed at 0.5 mbar and 180 °C for 1 to 5 h, aiming at enantiopure products. The products were characterized by DSC, HPLC,1H‐NMR spectroscopy and GPC. Zirconium sulfate tetrahydrate was found to be a suitable catalyst with respect to its selectivity and activity. The activity of this catalyst depends on the calcination conditions. By supporting the catalyst on an acidic material with a very high specific surface area, the catalytic activity can be strongly increased without losing selectivity. Products with nearly 100 mol% L‐lactic acid units were obtained even at high conversion and catalyst concentration.
Direct condensation of L-lactic acid was studied, aiming at highly crystalline and enantiopure high molecular weight (MW) products. Catalyst-free polylactic acid (PLA) with weight average MW of 80,000 g mol 21 , based on PLA standards, and a crystallinity of 75% is synthesized at 1408C in a fixed-bed reactor under vacuum or nitrogen purging. Supported zirconium sulfate is found to be an efficient and enantioselective catalyst for the melt and solid-state post-condensation of short-chain prepolymers. Small-molecule monohydroxy alcohols, aldehydes, di-and monocarboxylic acids (e.g., acrylic acid [1,700 ppm], propionic acid [1,800 ppm]) are detected in the lactic acid and prepolymers by high performance liquid chromatography, electron spray ionization, and electron impact mass spectroscopy. Thermal degradation of polymer chains, the crystallinity of the prepolymer, and the presence of monofunctional impurities are crucial parameters for the limitation of the MW of the resulting product.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.